Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 176 participants.
Also called NCT02936622
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 176 participants
- Sponsor
- Registry
-
NCT02936622
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, New Zealand
- Registry status
- Completed
Technical summary
Registry record NCT02936622. Randomized; single masking; primary purpose treatment. Start 2017-02-21 (actual); primary completion 2019-04-23 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Paclitaxel-coated Peripheral Stents Used in the Treatment of Femoropopliteal Stenoses
- Acronym
- XPEDITE
- Condition
- Peripheral Arterial Disease (PAD)
- Intervention (Device)
- Zilver® Paclitaxel-Eluting Peripheral Stent
- Intervention (Device)
- Zilver® Paclitaxel-Eluting Peripheral Stent with slower-dissolving polymer-free paclitaxel coating
- Intervention (Device)
- Zilver® Paclitaxel-Eluting Peripheral Stent with higher-dose polymer-free paclitaxel coating
- Lead sponsor
- Cook Group Incorporated
Record details
- Record id
cardio:ct-nct02936622- Content hash
fa56b52772e8b916bddb1a633dd6e6d89037a233fb5347c026c7f99ecf3eabfb